Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2020 at "Psychiatry Research"
DOI: 10.1016/j.psychres.2020.113017
Abstract: Pharmacogenomic tests used to guide clinical treatment for major depressive disorder (MDD) must be thoroughly validated. One important assessment of validity is the ability to predict medication blood levels, which reflect altered metabolism. Historically, the… read more here.
Keywords: citalopram escitalopram; blood; combinatorial pharmacogenomic; pharmacogenomic test ... See more keywords